NCT00828308 2022-03-08Neoadjuvant Weekly Ixabepilone for High Risk, Clinically Localized Prostate CancerBrown UniversityPhase 2 Completed16 enrolled 7 charts
NCT01079793 2020-08-20Radiation Therapy and Ixabepilone in Treating Patients With High-Risk Stage III Prostate Cancer After SurgeryUniversity of Texas Southwestern Medical CenterPhase 1/2 Withdrawn
NCT00672009 2018-10-24A Study of Ixabepilone Before Surgery for High-Risk Localized Prostate CancerCedars-Sinai Medical CenterPhase 2 Terminated11 enrolled